Cargando…

Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis

Background: Antipsychotic drugs may lead to side effects such as obesity, diabetes, dyslipidemia, and cardiovascular disease. The current systematic review and network meta-analysis analyzes and provides an update on the clinical performance of these add-ons in comparison to placebo on body weight a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuo, Chuanjun, Xu, Yong, Liu, Sha, Li, Jing, Zheng, Qishi, Gao, Xiangyang, Li, Shen, Jing, Rixing, Song, Xueqin, Yue, Weihua, Zhou, Chunhua, Upthegrove, Rachel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280187/ https://www.ncbi.nlm.nih.gov/pubmed/30546312 http://dx.doi.org/10.3389/fphar.2018.01393

Ejemplares similares

Successful Use of Add - On Topiramate for Antipsychotic - Induced Weight Gain
por: Shivakumar, Venkataram, et al.
Publicado: (2012)

Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model
por: Zhou, Chunhua, et al.
Publicado: (2020)

Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
por: Kang, Dongyu, et al.
Publicado: (2018)

COMT-Val158Met polymorphism modulates antipsychotic effects on auditory verbal hallucinations and temporal lobe gray matter volumes in healthy individuals—symptom relief accompanied by worrisome volume reductions
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial
por: Wang, Congjie, et al.
Publicado: (2020)

The Effect of Dopamine Antagonist Treatment on Auditory Verbal Hallucinations in Healthy Individuals Is Clearly Influenced by COMT Genotype and Accompanied by Corresponding Brain Structural and Functional Alterations: An Artificially Controlled Pilot Study
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Topiramate Add-on Lithium Carbonate for Treatment of Acute Mania
por: Mirsepassi, Zahra, et al.
Publicado: (2013)

S2. ANTIPSYCHOTICS RESULT IN WEIGHT GAIN BUT THE SEVERITY OF WEIGHT GAIN DIFFERS BETWEEN ANTIPSYCHOTICS
por: Bak, Maarten, et al.
Publicado: (2020)

Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series
por: Kirov, George, et al.
Publicado: (2005)

Comparative Cardio-Renal Outcomes of Type 2 Diabetes Patients Administered Glucagon-Like Peptide-1 Receptor Agonists: A Network Meta-Analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2021)

Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis
por: de Silva, Varuni Asanka, et al.
Publicado: (2016)

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series
por: Prasad, Femin, et al.
Publicado: (2023)

Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis
por: Luo, Chao, et al.
Publicado: (2019)

Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in Rats
por: Huang, Pokai, et al.
Publicado: (2018)

The Association Between Antipsychotics and Weight Gain and the Potential Role of Metformin Concomitant Use: A Retrospective Cohort Study
por: Hakami, Alqassem Y., et al.
Publicado: (2022)

Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia
por: Huang, Yinglin, et al.
Publicado: (2017)

Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia
por: Kakunje, Anil, et al.
Publicado: (2018)

Modulating Neuro-Immune-Induced Macrophage Polarization With Topiramate Attenuates Experimental Abdominal Aortic Aneurysm
por: Chen, Xing, et al.
Publicado: (2020)

Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
por: Bak, Maarten, et al.
Publicado: (2021)

Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study
por: Roberto, Giuseppe, et al.
Publicado: (2022)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Altered gene expression in antipsychotic-induced weight gain
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2019)

Combination approaches to reduce weight-gain induced by antipsychotics
por: Hofer, A.
Publicado: (2021)

Transcriptome Analysis of Liver Cancer Cell Huh-7 Treated With Metformin
por: Li, Chun-Qing, et al.
Publicado: (2022)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology
por: Fitzgerald, Ita, et al.
Publicado: (2022)

Prevalence of Heavy Menstrual Bleeding and Its Associated Cognitive Risks and Predictive Factors in Women With Severe Mental Disorders
por: Shan, Jianmin, et al.
Publicado: (2022)

REalist Synthesis Of non-pharmacologicaL interVEntions for antipsychotic-induced weight gain (RESOLVE) in people living with severe mental illness (SMI)
por: Maidment, Ian D., et al.
Publicado: (2022)

Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
por: de Boer, Nini, et al.
Publicado: (2021)

Youth, Caregiver, and Prescriber Experiences of Antipsychotic-Related Weight Gain
por: Murphy, Andrea Lynn, et al.
Publicado: (2013)

The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
por: Bretler, Tali, et al.
Publicado: (2019)

The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
por: Libowitz, Mark R., et al.
Publicado: (2021)

Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder
por: Berlant, Jeffrey L
Publicado: (2004)

Effectiveness of dose-escalated topiramate monotherapy and add-on therapy in neurosurgery-related epilepsy: A prospective study
por: Liu, Yu-Tse, et al.
Publicado: (2020)

Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia
por: Hsieh, Stephanie, et al.
Publicado: (2021)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
por: Li, Ranran, et al.
Publicado: (2018)

Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
por: Bak, Maarten, et al.
Publicado: (2014)

The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
por: Morgan, Andrew P., et al.
Publicado: (2014)

Risk of weight gain for specific antipsychotic drugs: a meta-analysis
por: Spertus, Jacob, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2evva32in3uu2b82cp57esdf0s